Cytokines have shown great potential in tumor immunotherapy. Although only a few drugs have been approved, many cytokine drugs developed based on next-generation cytokine drug development strategies have entered clinical trials and achieved the expected results. Based on a well-established cell therapy and immuno-oncology platform, Creative Biolabs has developed a series of cytokine-related activity alteration strategies.
Cytokines are regulators secreted by a variety of cells and involved in cellular communication, mainly including interleukin, interferon (IFN), some members of the tumor necrosis factor (TNF) superfamily, chemokines, and growth factors. Interleukins play an important role in activating and regulating innate and innate immune responses influenced by white blood cells. IFN has a range of other immunostimulatory and inhibitory functions, as well as antitumor activity and autoimmune effects. The TNF superfamily has pro-inflammatory or anti-inflammatory activity. Chemokines are composed of at least 47 structurally relevant cytokines that typically have the ability to stimulate cell migration, interact with the extracellular matrix (ECM), and thus control directed cell migration.
Fig.1 Chemokine ligands and receptors.1
Cytokines exhibit pleiotropy because they mediate more than one action, often acting on more than one cell type, as well as overlapping, i.e., two or more cytokines induce similar effects. Therefore, these two properties need to be taken into account when developing cytokine-based cancer immunotherapies. Creative Biolabs offers different activity alteration strategies to safely and effectively modulate cytokine activity for cancer immunity.
Strategies to enhance cytokine activity
The administration of natural cytokines can be limited by factors such as short half-lives and toxicity in vivo. Creative Biolabs achieves enhanced cytokine activity through a variety of methods such as extended half-life, fusion of other proteins such as immunoglobulins, their Fc regions, or albumin, and more.
Strategies to inhibit cytokine activity
Over the years, Creative Biolabs has developed an in-depth understanding of cytokine and cytokine receptor structure, receptor biology, and intracellular signaling mechanisms. With a focus on the new nature of cytokines and new engineering methods, you can trust us with your research project under the leadership of a team of professionals.
If you have any items of interest in the field of cancer immunotherapy of cytokines or have any questions, please do not hesitate to contact us for assistance. We provide you with technical support around the clock and respond quickly within a short time.
Reference
For Research Use Only | Not For Clinical Use